Isleworth Healthcare Acquisition Corp. (Nasdaq: ISLE) is a blank-check company that completed its initial public offering in 2021, targeting acquisition opportunities across the healthcare sector. Sponsored by Isleworth Healthcare Sponsor LLC, the vehicle focuses on healthcare services, medical technology, and life sciences as its primary search verticals. The company filed an 8-K with the Securities and Exchange Commission on June 10, 2022, under accession number 0001193125-22-171531, reflecting ongoing corporate activity during its post-IPO business combination search period. ISLE is among the healthcare-focused SPACs that came to market during the peak SPAC formation wave of 2020 and 2021. Sign up at SpacDesk for full filing history, deal timelines, and real-time data on ISLE and hundreds of other SPACs.